Categories: Business News

LANXESS Business Unit Advanced Industrial Intermediates Gains New Strengths/ Sets New Direction

Mumbai, Jan 13, 2015: LANXESS, the global specialty chemicals company is currently undergoing strategic realignment within the organization as part of its ‘Let’s LANXESS Again’ project. One of its largest business units Advanced Industrial Intermediates (AII), which until now catered to intermediates for agrochemicals, pharmaceuticals, dyes, coatings among others, will now also take over the antioxidants and accelerators businesses previously managed by the Rubber Chemicals (RUC) business unit at LANXESS.

The restructured business unit AII’s core business will continue to be the production and global marketing of high-grade industrial chemicals. The expansion of its current product portfolio through the addition of the business unitRUC’s antioxidants and accelerators fits in very well with the existing business model. This realignment will allow leveraging the synergies between the two erstwhile BUs, build a competitive sales structure with improved efficiencies, allow competitive access to raw materials and utilities, enable sharing of resources and optimizing costs. With its networkedglobal production organization and marketing operations, the AII business unit has been highly successful in the past, even though its products are in an environment of stiff competition from the products of other suppliers.

“In the AII business unit we operate a chemical business that has long-term perspectives. This is based largely on sustainable customer relations and trust built up over many years in the markets in question. Similarly, we want to develop strong relations with the customers of antioxidants and accelerators previously served by BU RUC. It is very important to me that we maintain long-term customer relationships in the future as well. We would continue to leverage these relationships and our market experiences for reaching out to customers with the rubber chemicals products” said Mr. Hubert Fink, Head – Business Unit, Advanced Industrial Intermediates, LANXESS AG.

“I believe that we have an excellent example of efficient, competitive and sustainable manufacturing with the BU AII’s manufacturing operations in Nagda, Madhya Pradesh. Under the realm of BU AII, the RUC production assets in Jhagadia will also be run in a similar manner. Thus, we now have a wider basket of products to offer to our customers in India and overseas. Together with these assets, an expanded portfolio and our capabilities, I am optimistic that we will be able to leverage the synergies for profitable growth”, added Mr. Neelanjan Banerjee, Senior Vice President – BU AII and Senior Executive Director, LANXESS India.CCI Newswire

The Pharma Times News Bureau

Recent Posts

Esaote Group Expands Production in India

Noida, November 08, 2024: Esaote Group, a leading Italian innovator in medical imaging - ultrasound,…

17 hours ago

In Q2 FY25, AGI Greenpac Limited posts EBITDA of ₹166 crore up by 20% Y-o-Y and PAT of Rs ₹72 crore up by 28%

Gurugram, November 08, 2024: AGI Greenpac Limited, a focused Packaging Products company, today announced its financial…

17 hours ago

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

2 days ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

2 days ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

2 days ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

2 days ago